Literature DB >> 28191526

Decreased regional left ventricular myocardial strain in type 1 diabetic children: a first sign of diabetic cardiomyopathy?

Amir Hodzic1, Virginie Ribault2, Pascale Maragnes1, Paul Milliez1, Eric Saloux1, Fabien Labombarda.   

Abstract

BACKGROUND AND OBJECTIVES: Type 1 diabetes is a major cardiovascular risk factor associated with an excess of mortality in young adults due to premature cardiovascular events, which includes heart failure. The relation between type 1 diabetes and cardiac structure and function in children was poorly documented. Our study investigates (1) whether type 1 diabetic children have echocardiographic signs of subclinical cardiac dysfunction assessed by tissue Doppler strain and (2) whether state of metabolic control and diabetes duration have any influence on the cardiac event.
METHODS: Standard echocardiography and tissue Doppler imaging were prospectively performed in type 1 diabetic children. Left ventricular dimensions, standard indices of systolic and diastolic function, and septal longitudinal strain were investigated.
RESULTS: Thirty consecutive asymptomatic diabetic children (age: 12.4 [5-17] years; males: 53%) were compared to 30 age and sex-matched healthy control subjects. Left ventricular mass index and diastolic septal thickness were significantly increased in diabetic children. There was no difference between two groups as regards the left ventricular ejection fraction and conventional mitral Doppler parameters (E, A, Ea). The global longitudinal systolic strain and strain rate were found to be decreased in children with diabetes. The global longitudinal early diastolic strain rate (Esr) was negatively correlated with metabolic control. Longitudinal strain was not correlated with diabetes duration.
CONCLUSION: Children with Type 1 diabetes had subclinical alterations in left ventricular size and longitudinal myocardial deformation.

Entities:  

Keywords:  childrend; left ventricular size; longitudinal myocardial deformation; type 1 diabetes

Year:  2016        PMID: 28191526      PMCID: PMC5290905          DOI: 10.1515/jtim-2016-0025

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


  34 in total

1.  Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI.

Authors:  Joost Lumens; Tammo Delhaas; Theo Arts; Brett R Cowan; Alistair A Young
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-05       Impact factor: 4.733

2.  Comparative usefulness of myocardial velocity gradient in detecting ischemic myocardium by a dobutamine challenge.

Authors:  H Tsutsui; M Uematsu; H Shimizu; M Yamagishi; N Tanaka; H Matsuda; K Miyatake
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

3.  The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus.

Authors:  S P Laing; A J Swerdlow; S D Slater; J L Botha; A C Burden; N R Waugh; A W Smith; R D Hill; P J Bingley; C C Patterson; Z Qiao; H Keen
Journal:  Diabet Med       Date:  1999-06       Impact factor: 4.359

4.  Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.

Authors:  Marcus Lind; Ioannis Bounias; Marita Olsson; Soffia Gudbjörnsdottir; Ann-Marie Svensson; Annika Rosengren
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

5.  Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael L Chuang; Carol J Salton; Caroline S Fox; Susan J Blease; Susan B Yeon; Warren J Manning; Christopher J O'Donnell
Journal:  Circ Cardiovasc Imaging       Date:  2010-03-05       Impact factor: 7.792

Review 6.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Zhi You Fang; Johannes B Prins; Thomas H Marwick
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

7.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors:  John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

8.  Body Mass Index variations: centiles from birth to 87 years.

Authors:  M F Rolland-Cachera; T J Cole; M Sempé; J Tichet; C Rossignol; A Charraud
Journal:  Eur J Clin Nutr       Date:  1991-01       Impact factor: 4.016

9.  Evaluation of subclinical left ventricular dysfunction in diabetic patients: longitudinal strain velocities and left ventricular dyssynchrony by two-dimensional speckle tracking echocardiography study.

Authors:  Arezoo Zoroufian; Tannaz Razmi; Mohsen Taghavi-Shavazi; Masoumeh Lotfi-Tokaldany; Arash Jalali
Journal:  Echocardiography       Date:  2013-10-18       Impact factor: 1.724

Review 10.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

View more
  4 in total

1.  Left ventricular systolic dysfunction predicts long-term major microvascular complication outcomes in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications (EDC) study of childhood onset diabetes.

Authors:  Jingchuan Guo; Rachel G Miller; Tina Costacou; William P Follansbee; Trevor J Orchard
Journal:  J Diabetes Complications       Date:  2017-12-28       Impact factor: 2.852

Review 2.  Cardiovascular disease in young People with Type 1 Diabetes: Search for Cardiovascular Biomarkers.

Authors:  Michal Schäfer; Kristen J Nadeau; Jane E B Reusch
Journal:  J Diabetes Complications       Date:  2020-06-06       Impact factor: 2.852

3.  miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway.

Authors:  Ying Miao; Qin Wan; Xiaoyu Liu; Yu Wang; Yi Luo; Dan Liu; Nengbo Lin; Honggang Zhou; Jiyuan Zhong
Journal:  Biomed Res Int       Date:  2017-12-18       Impact factor: 3.411

4.  Use of strain, strain rate, tissue velocity imaging, and endothelial function for early detection of cardiovascular involvement in young diabetics.

Authors:  Atul Kaushik; Aditya Kapoor; Preeti Dabadghao; Roopali Khanna; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Pravin K Goel; Archana Sinha
Journal:  Ann Pediatr Cardiol       Date:  2021-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.